Online inquiry

IVTScrip™ mRNA-Human ADRBK2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14370MR)

This product GTTS-WK14370MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADRBK2 protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_005160.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 157
UniProt ID P35626
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADRBK2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14370MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK8346MR IVTScrip™ mRNA-Human ADGRL2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRL2
GTTS-WK10170MR IVTScrip™ mRNA-Human ADRBK2, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADRBK2
GTTS-WK14298MR IVTScrip™ mRNA-Human ADAMTS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS1
GTTS-WK0921MR IVTScrip™ mRNA-Human Go-alpha, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA Go-alpha
GTTS-WK23897MR IVTScrip™ mRNA-Human ASB16-AS1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASB16-AS1
GTTS-WK14961MR IVTScrip™ mRNA-Human ANXA3, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANXA3
GTTS-WK11784MR IVTScrip™ mRNA-Human ABTB1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABTB1
GTTS-WK21514MR IVTScrip™ mRNA-Human ANKRD28, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD28
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →